
|Videos|March 31, 2022
A Role for Single Agent TKI Therapies in Treating Renal Cell Carcinoma
Oncologists debate whether TKI monotherapy has a place in renal cell carcinoma treatment after the CLEAR trial.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Modifiable Risk Factors Suggest Potential for Improving Cancer Prevention
2
Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC
3
2026 Tandem Meetings: Whatโs the Latest Research in Multiple Myeloma?
4
Outlining Advances in AI For Breast Cancer Screening/Radiomics
5















































